Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
SK Hynix, a subsidiary of SK Square, has decided to invest approximately KRW 5.296T in the construction of the M15X fab in Cheongju to expand next-generation DRAM production capacity.
📊 [Key Disclosure Details & Financial Summary]
- Name of Subsidiary: SK Hynix Inc.
- Investment Type: Facility Expansion (Target: Construction of Cheongju M15X)
- Total Investment Amount: KRW 5,296,200,000,000 (approx. KRW 5.296T)
- Equity Capital: KRW 53,503,752,397,611 (approx. KRW 53.504T, based on latest fiscal year-end consolidated statement)
- Ratio to Equity Capital: 9.90%
- Large Corporation Status: Applicable
- Purpose of Investment: Preemptive capacity expansion of next-generation DRAM to respond to market demand
- Investment Period: 2024-04-24 to 2026-10-30
- Board Resolution Date: 2024-04-24 (6 Outside Directors attended)
- Related Disclosure: Fair Disclosure on Future Business/Management Plan (2022-09-06)
- Additional Notes: Investment amount and timeline are subject to change depending on progress and changes in the business environment; the start date corresponds to the board resolution date.
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Verification of Facility Investment Progress and Completion
This disclosure is reported by SK Square to inform the market of a major capital expenditure decided by its subsidiary, SK Hynix, for next-generation DRAM capacity expansion. Tracking whether the planned investment is executed as scheduled over the investment period (April 24, 2024, to October 30, 2026) is key to evaluating whether the facility expansion transaction achieves full completion. Further details and potential adjustments can be confirmed through subsequent disclosures or periodic financial reports.
📢 Disclaimer & Source Notice
Source: This content was newly generated and structured based on official submission data from the Financial Supervisory Service DART system.
Investment Risk Warning: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For compliance inquiries or copyright-related requests, please contact ksb220805@gmail.com.
